UniProt ID | PTN11_HUMAN | |
---|---|---|
UniProt AC | Q06124 | |
Protein Name | Tyrosine-protein phosphatase non-receptor type 11 | |
Gene Name | PTPN11 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 597 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. Positively regulates MAPK signal transduction pathway. [PubMed: 28074573 Dephosphorylates GAB1, ARHGAP35 and EGFR] | |
Protein Sequence | MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKGHEYTNIKYSLADQTSGDQSPLPPCTPTPPCAEMREDSARVYENVGLMQQQKSFR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MTSRRWFHP ------CCCCCCCCC | 30.82 | 19413330 | |
28 | Phosphorylation | LTRGVDGSFLARPSK EECCCCCCEECCCCC | 16.78 | 17855441 | |
34 | Phosphorylation | GSFLARPSKSNPGDF CCEECCCCCCCCCCC | 43.07 | 23312004 | |
35 | Ubiquitination | SFLARPSKSNPGDFT CEECCCCCCCCCCCE | 57.86 | 33845483 | |
35 | Malonylation | SFLARPSKSNPGDFT CEECCCCCCCCCCCE | 57.86 | 26320211 | |
36 | Phosphorylation | FLARPSKSNPGDFTL EECCCCCCCCCCCEE | 53.23 | 20873877 | |
42 | Phosphorylation | KSNPGDFTLSVRRNG CCCCCCCEEEEEECC | 23.90 | 28270605 | |
52 | Phosphorylation | VRRNGAVTHIKIQNT EEECCEEEEEEEEEC | 19.83 | 30576142 | |
55 | Acetylation | NGAVTHIKIQNTGDY CCEEEEEEEEECCCE | 30.54 | 25953088 | |
59 | Phosphorylation | THIKIQNTGDYYDLY EEEEEEECCCEECCC | 18.30 | 23927012 | |
62 | Phosphorylation | KIQNTGDYYDLYGGE EEEECCCEECCCCCC | 10.54 | 25159151 | |
63 | Phosphorylation | IQNTGDYYDLYGGEK EEECCCEECCCCCCH | 12.29 | 27273156 | |
66 | Phosphorylation | TGDYYDLYGGEKFAT CCCEECCCCCCHHHH | 21.86 | 23927012 | |
73 | Phosphorylation | YGGEKFATLAELVQY CCCCHHHHHHHHHHH | 29.63 | - | |
80 | Phosphorylation | TLAELVQYYMEHHGQ HHHHHHHHHHHHCCC | 9.41 | - | |
82 | Sulfoxidation | AELVQYYMEHHGQLK HHHHHHHHHHCCCCC | 3.17 | 30846556 | |
91 | Malonylation | HHGQLKEKNGDVIEL HCCCCCHHCCCEEEE | 65.72 | 26320211 | |
91 | Acetylation | HHGQLKEKNGDVIEL HCCCCCHHCCCEEEE | 65.72 | 25953088 | |
99 | Acetylation | NGDVIELKYPLNCAD CCCEEEEEEECCCCC | 31.84 | 26051181 | |
119 | Ubiquitination | WFHGHLSGKEAEKLL CCCCCCCHHHHHHHH | 37.88 | 32015554 | |
120 | Ubiquitination | FHGHLSGKEAEKLLT CCCCCCHHHHHHHHH | 50.83 | 32015554 | |
123 | Ubiquitination | HLSGKEAEKLLTEKG CCCHHHHHHHHHHCC | 45.38 | 33845483 | |
124 | Ubiquitination | LSGKEAEKLLTEKGK CCHHHHHHHHHHCCC | 56.71 | 33845483 | |
131 | Ubiquitination | KLLTEKGKHGSFLVR HHHHHCCCCCCEEEE | 56.72 | 29967540 | |
131 | Malonylation | KLLTEKGKHGSFLVR HHHHHCCCCCCEEEE | 56.72 | 26320211 | |
131 | Acetylation | KLLTEKGKHGSFLVR HHHHHCCCCCCEEEE | 56.72 | 25953088 | |
140 | Phosphorylation | GSFLVRESQSHPGDF CCEEEEECCCCCCCE | 26.81 | 25159151 | |
142 | Phosphorylation | FLVRESQSHPGDFVL EEEEECCCCCCCEEE | 40.71 | 25159151 | |
153 | Phosphorylation | DFVLSVRTGDDKGES CEEEEEEECCCCCCC | 42.69 | - | |
156 | Ubiquitination | LSVRTGDDKGESNDG EEEEECCCCCCCCCC | 63.30 | 24816145 | |
157 | Ubiquitination | SVRTGDDKGESNDGK EEEECCCCCCCCCCC | 70.13 | 24816145 | |
160 | Phosphorylation | TGDDKGESNDGKSKV ECCCCCCCCCCCCCE | 49.22 | 26552605 | |
165 | Phosphorylation | GESNDGKSKVTHVMI CCCCCCCCCEEEEEE | 37.58 | 26552605 | |
178 | Acetylation | MIRCQELKYDVGGGE EEEEEEEEEECCCCC | 38.36 | 26051181 | |
179 | Phosphorylation | IRCQELKYDVGGGER EEEEEEEEECCCCCC | 28.61 | - | |
189 | Phosphorylation | GGGERFDSLTDLVEH CCCCCCCCHHHHHHH | 30.38 | 23312004 | |
191 | Phosphorylation | GERFDSLTDLVEHYK CCCCCCHHHHHHHHH | 31.10 | 23312004 | |
197 | Ubiquitination | LTDLVEHYKKNPMVE HHHHHHHHHHCCHHH | 15.34 | 21890473 | |
197 | Phosphorylation | LTDLVEHYKKNPMVE HHHHHHHHHHCCHHH | 15.34 | 23312004 | |
198 | Acetylation | TDLVEHYKKNPMVET HHHHHHHHHCCHHHH | 48.24 | 23954790 | |
198 | Ubiquitination | TDLVEHYKKNPMVET HHHHHHHHHCCHHHH | 48.24 | 21890473 | |
198 (in isoform 1) | Ubiquitination | - | 48.24 | 21890473 | |
198 (in isoform 2) | Ubiquitination | - | 48.24 | 21890473 | |
198 (in isoform 3) | Ubiquitination | - | 48.24 | 21890473 | |
213 | Acetylation | LGTVLQLKQPLNTTR HHHHHHHCCCCCCCC | 36.59 | 25953088 | |
228 | Phosphorylation | INAAEIESRVRELSK CCHHHHHHHHHHHHH | 41.56 | 21130716 | |
234 | Phosphorylation | ESRVRELSKLAETTD HHHHHHHHHHHHHCH | 22.37 | 29449344 | |
235 | Ubiquitination | SRVRELSKLAETTDK HHHHHHHHHHHHCHH | 65.43 | 29967540 | |
242 | Ubiquitination | KLAETTDKVKQGFWE HHHHHCHHHHHHHHH | 49.60 | 29967540 | |
242 | Acetylation | KLAETTDKVKQGFWE HHHHHCHHHHHHHHH | 49.60 | 25953088 | |
244 | Ubiquitination | AETTDKVKQGFWEEF HHHCHHHHHHHHHHH | 50.90 | 29967540 | |
244 | 2-Hydroxyisobutyrylation | AETTDKVKQGFWEEF HHHCHHHHHHHHHHH | 50.90 | - | |
260 | Ubiquitination | TLQQQECKLLYSRKE HHHHHHHHHHHHCHH | 40.55 | 29967540 | |
263 | Phosphorylation | QQECKLLYSRKEGQR HHHHHHHHHCHHHHC | 19.50 | 20736484 | |
264 | Phosphorylation | QECKLLYSRKEGQRQ HHHHHHHHCHHHHCH | 36.52 | 24719451 | |
274 | Acetylation | EGQRQENKNKNRYKN HHHCHHCCCCCCCCC | 69.42 | 18526083 | |
276 | Acetylation | QRQENKNKNRYKNIL HCHHCCCCCCCCCCC | 44.40 | 18526093 | |
279 | Phosphorylation | ENKNKNRYKNILPFD HCCCCCCCCCCCCCC | 20.13 | 18707149 | |
280 | Acetylation | NKNKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 19608861 | |
280 | Ubiquitination | NKNKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 29967540 | |
280 | Malonylation | NKNKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 26320211 | |
302 | Phosphorylation | GDPNEPVSDYINANI CCCCCCHHHHCCCEE | 35.10 | 29978859 | |
304 | Phosphorylation | PNEPVSDYINANIIM CCCCHHHHCCCEEEC | 6.64 | 25884760 | |
316 | Phosphorylation | IIMPEFETKCNNSKP EECCCCCCCCCCCCC | 46.33 | 26552605 | |
317 | Ubiquitination | IMPEFETKCNNSKPK ECCCCCCCCCCCCCC | 27.97 | 29967540 | |
355 | Sulfoxidation | ENSRVIVMTTKEVER CCCEEEEEECCCHHC | 2.43 | 30846556 | |
357 | Ubiquitination | SRVIVMTTKEVERGK CEEEEEECCCHHCCC | 13.70 | 24816145 | |
358 | Ubiquitination | RVIVMTTKEVERGKS EEEEEECCCHHCCCC | 51.07 | 24816145 | |
358 | Acetylation | RVIVMTTKEVERGKS EEEEEECCCHHCCCC | 51.07 | 26051181 | |
370 | Phosphorylation | GKSKCVKYWPDEYAL CCCCCCCCCCCHHHH | 11.19 | 28270605 | |
375 | Phosphorylation | VKYWPDEYALKEYGV CCCCCCHHHHHHHCC | 25.31 | 28270605 | |
389 | Ubiquitination | VMRVRNVKESAAHDY CEEEECCCHHHHCCC | 49.88 | 29967540 | |
389 | 2-Hydroxyisobutyrylation | VMRVRNVKESAAHDY CEEEECCCHHHHCCC | 49.88 | - | |
397 | Phosphorylation | ESAAHDYTLRELKLS HHHHCCCCHHHHCHH | 25.95 | 24719451 | |
401 | Ubiquitination | HDYTLRELKLSKVGQ CCCCHHHHCHHHHHH | 5.67 | 27667366 | |
402 | Ubiquitination | DYTLRELKLSKVGQA CCCHHHHCHHHHHHH | 46.06 | 27667366 | |
415 | Phosphorylation | QALLQGNTERTVWQY HHHHCCCCCCEEEEE | 33.40 | 17855441 | |
486 | Acetylation | LIDIIREKGVDCDID HHHHHHHHCCCCCCC | 55.15 | 23954790 | |
486 | Malonylation | LIDIIREKGVDCDID HHHHHHHHCCCCCCC | 55.15 | 26320211 | |
496 | Acetylation | DCDIDVPKTIQMVRS CCCCCCCHHHHHHHH | 59.10 | 26051181 | |
496 | Malonylation | DCDIDVPKTIQMVRS CCCCCCCHHHHHHHH | 59.10 | 26320211 | |
503 | Phosphorylation | KTIQMVRSQRSGMVQ HHHHHHHHCCCCCCC | 20.66 | 29438985 | |
511 | Phosphorylation | QRSGMVQTEAQYRFI CCCCCCCCHHHHHHH | 23.13 | 29438985 | |
515 | Phosphorylation | MVQTEAQYRFIYMAV CCCCHHHHHHHHHHH | 17.97 | 20090780 | |
519 | Phosphorylation | EAQYRFIYMAVQHYI HHHHHHHHHHHHHHH | 4.02 | 23898821 | |
535 | Phosphorylation | TLQRRIEEEQKSKRK HHHHHHHHHHHHHHC | 64.45 | 24719451 | |
535 | Ubiquitination | TLQRRIEEEQKSKRK HHHHHHHHHHHHHHC | 64.45 | 24816145 | |
536 | Ubiquitination | LQRRIEEEQKSKRKG HHHHHHHHHHHHHCC | 50.98 | 24816145 | |
538 | Ubiquitination | RRIEEEQKSKRKGHE HHHHHHHHHHHCCCC | 62.31 | 29967540 | |
539 | Ubiquitination | RIEEEQKSKRKGHEY HHHHHHHHHHCCCCC | 37.07 | 24816145 | |
539 | Phosphorylation | RIEEEQKSKRKGHEY HHHHHHHHHHCCCCC | 37.07 | 24719451 | |
540 | Ubiquitination | IEEEQKSKRKGHEYT HHHHHHHHHCCCCCC | 66.23 | 24816145 | |
542 | Phosphorylation | EEQKSKRKGHEYTNI HHHHHHHCCCCCCCC | 69.25 | 8041791 | |
542 | Ubiquitination | EEQKSKRKGHEYTNI HHHHHHHCCCCCCCC | 69.25 | 29967540 | |
546 | Phosphorylation | SKRKGHEYTNIKYSL HHHCCCCCCCCCEEE | 10.22 | 27273156 | |
547 | Phosphorylation | KRKGHEYTNIKYSLA HHCCCCCCCCCEEEC | 27.73 | 27273156 | |
551 | Phosphorylation | HEYTNIKYSLADQTS CCCCCCCEEECCCCC | 12.72 | 28122231 | |
552 | Phosphorylation | EYTNIKYSLADQTSG CCCCCCEEECCCCCC | 16.45 | 25159151 | |
557 | Phosphorylation | KYSLADQTSGDQSPL CEEECCCCCCCCCCC | 34.91 | 23401153 | |
558 | Phosphorylation | YSLADQTSGDQSPLP EEECCCCCCCCCCCC | 34.44 | 30278072 | |
561 | Phosphorylation | ADQTSGDQSPLPPCT CCCCCCCCCCCCCCC | 50.93 | 32142685 | |
562 | Phosphorylation | DQTSGDQSPLPPCTP CCCCCCCCCCCCCCC | 32.89 | 30278072 | |
564 | Phosphorylation | TSGDQSPLPPCTPTP CCCCCCCCCCCCCCC | 10.02 | 24719451 | |
566 | Phosphorylation | GDQSPLPPCTPTPPC CCCCCCCCCCCCCCC | 42.15 | 32142685 | |
568 | Phosphorylation | QSPLPPCTPTPPCAE CCCCCCCCCCCCCHH | 35.65 | 25159151 | |
568 | O-linked_Glycosylation | QSPLPPCTPTPPCAE CCCCCCCCCCCCCHH | 35.65 | OGP | |
570 | Phosphorylation | PLPPCTPTPPCAEMR CCCCCCCCCCCHHHC | 23.01 | 25159151 | |
570 | O-linked_Glycosylation | PLPPCTPTPPCAEMR CCCCCCCCCCCHHHC | 23.01 | OGP | |
576 | Phosphorylation | PTPPCAEMREDSARV CCCCCHHHCCCHHHH | 2.79 | 11781100 | |
580 | Phosphorylation | CAEMREDSARVYENV CHHHCCCHHHHHHHH | 17.14 | 21945579 | |
584 | Phosphorylation | REDSARVYENVGLMQ CCCHHHHHHHHHHHH | 9.02 | 12634870 | |
589 | Ubiquitination | RVYENVGLMQQQKSF HHHHHHHHHHHHHHC | 2.14 | 23000965 | |
590 | Sumoylation | VYENVGLMQQQKSFR HHHHHHHHHHHHHCC | 2.51 | - | |
590 | Sulfoxidation | VYENVGLMQQQKSFR HHHHHHHHHHHHHCC | 2.51 | 30846556 | |
590 | Ubiquitination | VYENVGLMQQQKSFR HHHHHHHHHHHHHCC | 2.51 | 23000965 | |
591 | Phosphorylation | YENVGLMQQQKSFR- HHHHHHHHHHHHCC- | 47.82 | 24719451 | |
593 | Ubiquitination | NVGLMQQQKSFR--- HHHHHHHHHHCC--- | 26.86 | 23000965 | |
594 | Ubiquitination | VGLMQQQKSFR---- HHHHHHHHHCC---- | 47.42 | 23000965 | |
594 | Acetylation | VGLMQQQKSFR---- HHHHHHHHHCC---- | 47.42 | 25953088 | |
595 | Phosphorylation | GLMQQQKSFR----- HHHHHHHHCC----- | 23.16 | 23401153 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
73 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
73 | T | Phosphorylation | Kinase | PKACA | P17612 | PSP |
189 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
189 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
542 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | PSP |
542 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | GPS |
542 | Y | Phosphorylation | Kinase | PDGFRB | P05622 | PSP |
542 | Y | Phosphorylation | Kinase | PDGFR | - | Uniprot |
542 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
546 | Y | Phosphorylation | Kinase | FYN | P06241 | GPS |
546 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | GPS |
546 | Y | Phosphorylation | Kinase | PDGFR-FAMILY | - | GPS |
546 | Y | Phosphorylation | Kinase | PDGFRB | P05622 | GPS |
546 | Y | Phosphorylation | Kinase | PGFRB | P09619 | PhosphoELM |
576 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
576 | S | Phosphorylation | Kinase | PKCB | P05771 | PSP |
576 | S | Phosphorylation | Kinase | PKCB ISO2 | P05771-2 | PSP |
576 | S | Phosphorylation | Kinase | PKCH | P24723 | PSP |
580 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | PSP |
580 | Y | Phosphorylation | Kinase | PDGFR | - | Uniprot |
580 | S | Phosphorylation | Kinase | PRKCH | P24723 | GPS |
580 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
580 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
584 | Y | Phosphorylation | Kinase | PDGFR-FAMILY | - | GPS |
584 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | GPS |
591 | S | Phosphorylation | Kinase | PKCH | P24723 | PSP |
591 | S | Phosphorylation | Kinase | PKCB ISO2 | P05771-2 | PSP |
591 | S | Phosphorylation | Kinase | PKCB | P05771 | PSP |
591 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
595 | S | Phosphorylation | Kinase | PRKCH | P24723 | GPS |
595 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
595 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTN11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTN11_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
151100 | LEOPARD syndrome 1 (LPRD1) | |||||
163950 | Noonan syndrome 1 (NS1) | |||||
607785 | Leukemia, juvenile myelomonocytic (JMML) | |||||
156250 | Metachondromatosis (MC) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-562, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-584 AND SER-595, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62 AND TYR-584, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62; TYR-63 AND TYR-584,AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62; TYR-63 AND TYR-584,AND MASS SPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-584, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND MASSSPECTROMETRY. |